Table 2.
Between group differences in gray matter volume.
Contrast | Region | p value | KE/radius | z value | x | y | z |
---|---|---|---|---|---|---|---|
1. Whole brain analysis | |||||||
p uncorr. | |||||||
ARMS < HC | Middle frontal gyrus | 0.035 | 790 | 3.59 | −33 | 57 | 16 |
ARMS-AD < HC | Superior frontal gyrus | 0.028 | 874 | 3.98 | −33 | 57 | 18 |
ARMS-nonAD < ARMS-AD | Left superior parietal lobe | 0.023 | 944 | 4.33 | −32 | −40 | 45 |
2. Region of interest | |||||||
p FWE-corr* | |||||||
ARMS-AD < ARMS-nonAD | Left hippocampus | 0.029 | 5 mm | 2.86 | −18 | −19 | −17 |
ARMS-AD < ARMS-nonAD | Right precuneus | 0.042 | 10 mm | 3.23 | 10 | −78 | 51 |
The data presented here are from ANOVA of 3 included groups (ARMS-AD, ARMS-nonAD, HC) at a threshold of p < 0.005 uncorrected across the whole brain.
There were no significant differences in the following contrasts: ARMS > HC, ARMS-AD > HC, ARMS-nonAD vs. HC, and ARMS-nonAD > ARMS-AD.
Abbreviations: ARMS, at risk mental state; ARMS-AD, ARMS subjects currently receiving antidepressants; ARMS-nonAD, ARMS individuals without current antidepressant medication; HC, healthy controls; KE, voxels per cluster; x y z, coordinates according to the Montreal Neurological Institute.
Abbreviations: ARMS — at-risk mental state; ARMS-AD — ARMS with antidepressants; ARMS-nonAD — ARMS without antidepressants; KE — voxels per cluster.
p < 0.0125 required.